242 related articles for article (PubMed ID: 10617620)
1. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
[TBL] [Abstract][Full Text] [Related]
2. Anergy induction by dimeric TCR ligands.
Appel H; Seth NP; Gauthier L; Wucherpfennig KW
J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
[TBL] [Abstract][Full Text] [Related]
3. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
Wucherpfennig KW; Hafler DA; Strominger JL
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
[TBL] [Abstract][Full Text] [Related]
4. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
5. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
Gauthier L; Smith KJ; Pyrdol J; Kalandadze A; Strominger JL; Wiley DC; Wucherpfennig KW
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11828-33. PubMed ID: 9751750
[TBL] [Abstract][Full Text] [Related]
6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
7. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.
Arimilli S; Mumm JB; Nag B
Immunol Cell Biol; 1996 Feb; 74(1):96-104. PubMed ID: 8934660
[TBL] [Abstract][Full Text] [Related]
9. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
Nag B; Arimilli S; Mukku PV; Astafieva I
J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
[TBL] [Abstract][Full Text] [Related]
10. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
11. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
[TBL] [Abstract][Full Text] [Related]
12. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Chang JW; Mechling DE; Bächinger HP; Burrows GG
J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
[TBL] [Abstract][Full Text] [Related]
13. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
Mukku PV; Passmore D; Phan D; Nag B
Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
[TBL] [Abstract][Full Text] [Related]
14. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations.
Nag B; Mukku PV; Arimilli S; Phan D; Deshpande SV; Winkelhake JL
Mol Immunol; 1994 Oct; 31(15):1161-8. PubMed ID: 7523870
[TBL] [Abstract][Full Text] [Related]
15. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B
J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765
[TBL] [Abstract][Full Text] [Related]
16. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
Chou YK; Weinberg AD; Buenafe A; Bourdette DN; Whitham R; Kaleeba JA; Robey IF; Kavanagh DG; Offner H; Vandenbark AA
J Neurosci Res; 1996 Sep; 45(6):838-51. PubMed ID: 8892096
[TBL] [Abstract][Full Text] [Related]
17. The 3A6-TCR/superagonist/HLA-DR2a complex shows similar interface and reduced flexibility compared to the complex with self-peptide.
Salutari I; Martin R; Caflisch A
Proteins; 2020 Jan; 88(1):31-46. PubMed ID: 31237711
[TBL] [Abstract][Full Text] [Related]
18. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
[TBL] [Abstract][Full Text] [Related]
19. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
Nag B; Deshpande SV; Sharma SD; Clark BR
J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
